MED-EL E-Bag
Since our founders developed one of the world’s first cochlear implants in 1975, MED-EL has set new standards in hearing implant technologies, developing and manufacturing technologically advanced hearing solutions for people with varying degrees of hearing loss. MED-EL hearing implant systems combine the latest scientific advances, engineering, and manufacturing techniques for performance, safety, and reliability.
MED-EL is committed to providing industry-leading technology throughout every part of the hearing journey. We worked with the FDA to expand our indications, becoming the first cochlear implant company to approve patients based off CNC word scores, and the only CI manufacturer with proven hearing preservation claims. Our portfolio of electrode arrays gives surgeons the widest selection of options for their patients. By using our exclusive OTOPLAN software, MED-EL provides them with the tools they need to select the best fit for that individual’s anatomy. Once implanted, clinics can leverage these OTOPLAN reports to program the system using Anatomy-Based Fitting to match the patient’s unique cochlea. Complete with built-in streaming, a convenient Touch Key, an ergonomic design, and all-day battery life with our NEW rechargeable batteries, MED-EL’s SONNET 3 audio processor allows patients to connect with the world around them more freely and fully.
Now, MED-EL cochlear implants have the youngest and broadest candidacy indications in the industry, which means your patients can get access to our groundbreaking hearing health technology sooner than ever before.
We hope you’ll join us at the symposia we’re offering this ACIA to learn more about the technological advances we’re making to help your patients achieve the closest to natural hearing.
